Lifecore Biomedical Ownership | Who Owns Lifecore Biomedical?


OverviewForecastRevenueFinancialsChartTranscripts

Lifecore Biomedical Ownership Summary


Lifecore Biomedical is owned by 66.57% institutional investors, 2.05% insiders, and 31.37% retail investors. Wynnefield capital is the largest institutional shareholder, holding 12.70% of LFCR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.10% of its assets in Lifecore Biomedical shares.

LFCR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLifecore Biomedical66.57%2.05%31.37%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustrySpecialty & Generic Drug Manufacturers Stocks43.51%11.55%44.95%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Wynnefield capital4.70M12.70%$33.11M
Legion partners asset management4.43M11.97%$35.99M
Greenhaven road investment management3.69M9.98%$30.00M
325 capital2.16M5.84%$15.22M
Blackrock funding, inc. /de1.87M5.06%$15.22M
Vanguard group1.53M4.45%$11.37M
Geode capital management685.75K2.00%$5.10M
Dcf advisers462.99K1.25%$3.76M
State street375.28K1.09%$2.79M
22nw, lp264.18K0.71%$22.63M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Legion partners asset management4.43M21.63%$35.99M
Wynnefield capital4.70M20.95%$33.11M
22nw, lp264.18K14.25%$22.63M
Greenhaven road investment management3.69M10.28%$30.00M
325 capital2.16M6.31%$15.22M
Dcf advisers462.99K1.74%$3.76M
Diametric capital, lp33.47K0.14%$271.79K
Quinn opportunity partners202.25K0.14%$1.64M
Lepercq multi-asset fund22.70K0.12%$168.66K
Wittenberg investment management17.22K0.06%$139.85K

Top Buyers

HolderShares% AssetsChange
Vanguard group1.53M0.00%215.44K
Blackrock funding, inc. /de1.87M0.00%109.91K
Millennium management100.81K0.00%100.81K
Geode capital management685.75K0.00%88.06K
Greenhaven road investment management3.69M10.28%78.69K

Top Sellers

HolderShares% AssetsChange
22nw, lp264.18K14.25%-1.49M
Invesco---555.61K
Deutsche bank ag\25.43K0.00%-290.29K
B. riley asset management---143.48K
Boothbay fund management---87.14K

New Positions

HolderShares% AssetsChangeValue
Millennium management100.81K0.00%100.81K$709.72K
Pale fire capital se30.69K0.03%30.69K$249.17K
Lepercq multi-asset fund22.70K0.12%22.70K$168.66K
Metlife investment management14.51K0.00%14.51K$107.83K
Gwn securities13.09K0.02%13.09K$106.29K

Sold Out

HolderChange
Ifp advisors-1.00
Cove street capital-1.00
Capital performance advisors llp-2.00
Allspring global investments-64.00
Russell investments group-84.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202586-1.15%24,649,1740.57%661.52%5011.11%18-5.26%
Mar 31, 20254-94.87%11,398,318-54.08%300.59%1-97.62%--100.00%
Dec 31, 202435-57.83%5,107,705-75.31%140.33%24-54.72%4-63.64%
Sep 30, 2024835.06%20,688,9251.65%671.50%5326.19%11-47.62%
Jun 30, 202479-3.66%20,352,578-5.60%661.34%42-2116.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF775.94K2.10%-
Vanguard Total Stock Mkt Idx Inv771.12K2.06%-17.01K
iShares Russell 2000 ETF633.22K1.71%-12.07K
Vanguard Institutional Extnd Mkt Idx Tr406.19K1.09%-177.16K
Invesco Dorsey Wright SmallCap Momt ETF359.37K0.97%-
Xtrackers S&P 500 2xLev Dly Swap ETF 1C315.72K0.86%-
Fidelity Small Cap Index273.11K0.73%21.46K
Tocqueville200.00K0.65%-50.00K
Fidelity Extended Market Index201.00K0.54%-525.00
iShares Russell 2000 Growth ETF184.80K0.50%-

Recent Insider Transactions


DateNameRoleActivityValue
May 23, 2025English Aron R.-Sell$649.39K
May 28, 2025English Aron R.-Sell$1.07M
May 27, 2025English Aron R.-Sell$7.41M
May 13, 2025English Aron R.-Sell$86.35K
May 08, 2025English Aron R.-Sell$35.69K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q2-10
2025 Q11-
2024 Q44-
2024 Q3--

LFCR Ownership FAQ


Who Owns Lifecore Biomedical?

Lifecore Biomedical shareholders are primarily institutional investors at 66.57%, followed by 2.05% insiders and 31.38% retail investors. The average institutional ownership in Lifecore Biomedical's industry, Specialty & Generic Drug Manufacturers Stocks, is 43.51%, which Lifecore Biomedical exceeds.

Who owns the most shares of Lifecore Biomedical?

Lifecore Biomedical’s largest shareholders are Wynnefield capital (4.7M shares, 12.70%), Legion partners asset management (4.43M shares, 11.97%), and Greenhaven road investment management (3.69M shares, 9.98%). Together, they hold 34.65% of Lifecore Biomedical’s total shares outstanding.

Does Blackrock own Lifecore Biomedical?

BlackRock is not among the top 10 institutional shareholders of Lifecore Biomedical.

Who is Lifecore Biomedical’s biggest shareholder by percentage of total assets invested?

Legion partners asset management is Lifecore Biomedical’s biggest shareholder by percentage of total assets invested, with 21.63% of its assets in 4.43M Lifecore Biomedical shares, valued at 35.99M$.

Who is the top mutual fund holder of Lifecore Biomedical shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Lifecore Biomedical shares, with 2.10% of its total shares outstanding invested in 775.94K Lifecore Biomedical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools